Learn More
Medchemexpress LLC FTISADTSK-13C6,15N2(TFA) | 96.04% | 1091.01 | 5 MG

Supplier: Medchemexpress LLC HYP3146S5MG
FTISADTSK-13C6,15N2 TFA is a 13C- and 15N-labeled stable isotope peptide derived from Trastuzumab. It is an endogenous stable signature peptide monitored by selected reaction monitoring (SRM) and is used as a tracer for quantitation during drug development.
- 13C- and 15N-labeled stable isotope peptide
- Derived from Trastuzumab
- Monitored by selected reaction monitoring (SRM)
- Used as a tracer for quantitation during drug development
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.